NO20070440L - Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt - Google Patents

Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt

Info

Publication number
NO20070440L
NO20070440L NO20070440A NO20070440A NO20070440L NO 20070440 L NO20070440 L NO 20070440L NO 20070440 A NO20070440 A NO 20070440A NO 20070440 A NO20070440 A NO 20070440A NO 20070440 L NO20070440 L NO 20070440L
Authority
NO
Norway
Prior art keywords
fibromyalgia
treatment
rheumatoid arthritis
neuropathic pain
gaboxadol
Prior art date
Application number
NO20070440A
Other languages
English (en)
Inventor
Bjarke Ebert
Connie Sanchez
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20070440L publication Critical patent/NO20070440L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)

Abstract

Foreliggende oppfinnelse vedrører anvendelsen av Gaboxadol for fremstillingen av medikamenter nyttige for behandlingen av nevropatisk smerte, fibromyalgi eller revmatoid artritt.
NO20070440A 2004-06-29 2007-01-25 Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt NO20070440L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2004/000460 WO2006053556A1 (en) 2004-06-29 2004-06-29 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis

Publications (1)

Publication Number Publication Date
NO20070440L true NO20070440L (no) 2007-01-25

Family

ID=34957949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070440A NO20070440L (no) 2004-06-29 2007-01-25 Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt

Country Status (13)

Country Link
US (1) US20050288371A1 (no)
EP (1) EP1761263A1 (no)
JP (1) JP2008504306A (no)
KR (1) KR20070034070A (no)
CN (1) CN1976700A (no)
AU (1) AU2004324938A1 (no)
BR (1) BRPI0418932A (no)
CA (1) CA2572302A1 (no)
EA (1) EA200700102A1 (no)
IL (1) IL180250A0 (no)
MX (1) MXPA06015196A (no)
NO (1) NO20070440L (no)
WO (1) WO2006053556A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812185B1 (fr) 2000-07-25 2003-02-28 Spine Next Sa Piece de liaison semi-rigide pour la stabilisation du rachis
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1848420A4 (en) 2005-01-28 2008-01-23 Merck & Co Inc POLYMORPHIC FORMS OF A GABAA AGONIST
US20070203216A1 (en) * 2006-02-14 2007-08-30 Bjarke Ebert Method of treating inflammatory diseases
US20070233211A1 (en) * 2006-04-04 2007-10-04 Galer Bradley S Methods and compositions for treating non-neuropathic pain
US20090048288A1 (en) * 2007-08-13 2009-02-19 H. Lundbeck A/S Method of treating stress-mediated depression
TW200920358A (en) * 2007-08-13 2009-05-16 Lundbeck & Co As H Method of treating stress-mediated depression
CN102552442B (zh) * 2010-12-07 2014-01-01 北京联合大学生物化学工程学院 一种治疗骨质增生的中药复方滴丸及其制备方法
CN103520138A (zh) * 2013-09-06 2014-01-22 潍坊锦博医药科技有限公司 一种治疗骨刺的新型膏药及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276676A (en) * 1979-07-30 1981-07-07 Presto Lock Company, Division Of Walter Kidde & Company, Inc. Handle mounting device
US4315934A (en) * 1979-09-24 1982-02-16 Sandoz Ltd. Organic compounds
US4362731A (en) * 1980-09-01 1982-12-07 Sandoz Ltd. Myotonolytic use of 4,5,6,7-tetrahydroisoxazolo [5,4-c] pyridin-3-ol and derivatives thereof
AR031473A1 (es) * 2000-11-20 2003-09-24 Lundbeck & Co As H Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
AU2002253857A1 (en) * 2001-01-08 2002-09-04 Centaur Pharmaceuticals, Inc. Use of aryl nitrone compounds in methods for treating neuropathic pain

Also Published As

Publication number Publication date
IL180250A0 (en) 2007-07-04
WO2006053556A1 (en) 2006-05-26
CN1976700A (zh) 2007-06-06
EP1761263A1 (en) 2007-03-14
US20050288371A1 (en) 2005-12-29
KR20070034070A (ko) 2007-03-27
CA2572302A1 (en) 2006-05-26
JP2008504306A (ja) 2008-02-14
BRPI0418932A (pt) 2007-11-27
AU2004324938A1 (en) 2006-05-26
EA200700102A1 (ru) 2007-06-29
MXPA06015196A (es) 2007-03-15

Similar Documents

Publication Publication Date Title
NO20070440L (no) Behandling av nevropatisk smerte, fibromyalgi eller revmatoid artritt
CY1118472T1 (el) Υποκατεστημενα ακυλανιλιδια και μεθοδοι χρησης αυτων
NO20090596L (no) Antivirale fosfinatforbindelser
NO20083153L (no) Kjemiske forbindelser
EA201390609A1 (ru) ПРОИЗВОДНЫЕ ГИДАНТОИНА, ПОЛЕЗНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ Kv3-КАНАЛОВ
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
ATE501210T1 (de) Titandioxid enthaltendes komposit
TN2009000291A1 (en) Inhibitors of mek
ATE427965T1 (de) Antikírper gegen 25-hydroxyvitamin d
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
EA201070238A1 (ru) Соединения пиримидина
CY1115975T1 (el) Ταπενταδολη για τη θεραπεια πονου σε αρθριτιδα
EA200700717A1 (ru) Сульфонамиды
TW200700064A (en) Novel compounds
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
EA200702352A1 (ru) Новые композиции нутрицевтиков
DE602007005697D1 (de) Verwendung von carrageenan zur behandlung von rhinovirus-infektionen
ATE472998T1 (de) Kationische liposomale zubereitungen zur behandlung von rheumatoider arthritis
EA200901080A1 (ru) Новые нуклеозидные аналоги для лечения вирусных инфекций
DE50307886D1 (de) Leitungsführungseinheit zur aktiven führung von leitungen, kabeln oder dergleichen
NO20072290L (no) Organiske forbindelser.
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application